Can Genomics Blow Up the Clinical Trial? | MIT Tech Review

Details of what I will call a 'shotgun' approach to incorporating genetics into clinical trials. The work being done here is definitely not 'blowing up the clinical trial' but rather doing a clinical trial on a larger, coordinated scale. The real power of genetics and drug design when we reach the reality of using tumor genetic results to reverse engineer therapies.

Permalink